A citation-based method for searching scientific literature

Miao Wang, Su-Fei He, Lei-Lei Liu, Xiao-Xia Sun, Fan Yang, Qian Ge, Wei-Kang Wong, Jing-Yan Meng. Oncol Rep 2017
Times Cited: 10







List of co-cited articles
25 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Pleiotropic Roles for ZEB1 in Cancer.
Julie Caramel, Maud Ligier, Alain Puisieux. Cancer Res 2018
164
30

ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1.
Peijing Zhang, Yongkun Wei, Li Wang, Bisrat G Debeb, Yuan Yuan, Jinsong Zhang, Jingsong Yuan, Min Wang, Dahu Chen, Yutong Sun,[...]. Nat Cell Biol 2014
289
30


ZEB1 confers chemotherapeutic resistance to breast cancer by activating ATM.
Xiang Zhang, Zhen Zhang, Qing Zhang, Quansheng Zhang, Peiqing Sun, Rong Xiang, Guosheng Ren, Shuang Yang. Cell Death Dis 2018
68
20

The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer.
Angela M Krebs, Julia Mitschke, María Lasierra Losada, Otto Schmalhofer, Melanie Boerries, Hauke Busch, Martin Boettcher, Dimitrios Mougiakakos, Wilfried Reichardt, Peter Bronsert,[...]. Nat Cell Biol 2017
534
20

A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer.
Simone Spaderna, Otto Schmalhofer, Falk Hlubek, Geert Berx, Andreas Eger, Susanne Merkel, Andreas Jung, Thomas Kirchner, Thomas Brabletz. Gastroenterology 2006
367
20

Clinical significance of Zinc finger E-box Binding homeobox 1 (ZEB1) in human gastric cancer.
Yoshinaga Okugawa, Yuji Toiyama, Koji Tanaka, Kohei Matsusita, Hiroyuki Fujikawa, Susumu Saigusa, Masaki Ohi, Yasuhiro Inoue, Yasuhiko Mohri, Keiichi Uchida,[...]. J Surg Oncol 2012
37
20

The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs.
Ulrich Wellner, Jörg Schubert, Ulrike C Burk, Otto Schmalhofer, Feng Zhu, Annika Sonntag, Bettina Waldvogel, Corinne Vannier, Douglas Darling, Axel zur Hausen,[...]. Nat Cell Biol 2009
20


The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression.
Cheryl McFarlane, Alyson A Kelvin, Michelle de la Vega, Ureshnie Govender, Christopher J Scott, James F Burrows, James A Johnston. Cancer Res 2010
68
20

The E3 deubiquitinase USP17 is a positive regulator of retinoic acid-related orphan nuclear receptor γt (RORγt) in Th17 cells.
Lei Han, Jing Yang, Xiuwen Wang, Qingsi Wu, Shuying Yin, Zhiyuan Li, Jing Zhang, Yue Xing, Zuojia Chen, Andy Tsun,[...]. J Biol Chem 2014
46
20

The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility.
Michelle de la Vega, Alyson A Kelvin, Dara J Dunican, Cheryl McFarlane, James F Burrows, Jakub Jaworski, Nigel J Stevenson, Karim Dib, Joshua Z Rappoport, Christopher J Scott,[...]. Nat Commun 2011
45
20

USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity.
James F Burrows, Alyson A Kelvin, Cheryl McFarlane, Roberta E Burden, Michael J McGrattan, Michelle De la Vega, Ureshnie Govender, Derek J Quinn, Karim Dib, Massimo Gadina,[...]. J Biol Chem 2009
66
20

A genomic and functional inventory of deubiquitinating enzymes.
Sebastian M B Nijman, Mark P A Luna-Vargas, Arno Velds, Thijn R Brummelkamp, Annette M G Dirac, Titia K Sixma, René Bernards. Cell 2005
20

Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability.
Ju-Mi Shin, Kyong-Jai Yoo, Myung-Sun Kim, Dongku Kim, Kwang-Hyun Baek. BMC Genomics 2006
29
20

Expression and functional implications of USP17 in glioma.
Manmiao Hu, Huairui Chen, Cong Han, Jin Lan, Yuanzhi Xu, Chao Li, Yajun Xue, Meiqing Lou. Neurosci Lett 2016
10
20

USP17- and SCFβTrCP--regulated degradation of DEC1 controls the DNA damage response.
Jihoon Kim, Sara D'Annibale, Roberto Magliozzi, Teck Yew Low, Petra Jansen, Indra A Shaltiel, Shabaz Mohammed, Albert J R Heck, Rene H Medema, Daniele Guardavaccaro. Mol Cell Biol 2014
21
20



Induction of USP17 by combining BET and HDAC inhibitors in breast cancer cells.
Gabor Borbely, Lars-Arne Haldosen, Karin Dahlman-Wright, Chunyan Zhao. Oncotarget 2015
56
20

USP17 is required for trafficking and oncogenic signaling of mutant EGFR in NSCLC cells.
Aidan P McCann, Peter Smyth, Francesco Cogo, William J McDaid, Lai Jiang, Jia Lin, Emma Evergren, Roberta E Burden, Sandra Van Schaeybroeck, Christopher J Scott,[...]. Cell Commun Signal 2018
8
25

The deubiquitinating enzyme USP17 is associated with non-small cell lung cancer (NSCLC) recurrence and metastasis.
Cheryl McFarlane, Suzanne McFarlane, Ian Paul, Kenneth Arthur, Michael Scheaff, Keith Kerr, Michael Stevenson, Dean A Fennell, James A Johnston. Oncotarget 2013
37
20


Dub3 controls DNA damage signalling by direct deubiquitination of H2AX.
M Rocío Delgado-Díaz, Yusé Martín, Anna Berg, Raimundo Freire, Veronique A J Smits. Mol Oncol 2014
32
20

Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A.
Yaron Pereg, Bob Y Liu, Karen M O'Rourke, Meredith Sagolla, Anwesha Dey, Laszlo Komuves, Dorothy M French, Vishva M Dixit. Nat Cell Biol 2010
98
20

MicroRNA‑643 regulates the expression of ZEB1 and inhibits tumorigenesis in osteosarcoma.
Huan Wang, Danmou Xing, Dong Ren, Wei Feng, Yan Chen, Zhiming Zhao, Zhihong Xiao, Zhengren Peng. Mol Med Rep 2017
17
10

[Research progress on Drynaria fortunei naringin on inflammation and bone activity].
Fang-ming Yin, Lian-bo Xiao, Yun Zhang. Zhongguo Gu Shang 2015
7
14

Zeb1 links epithelial-mesenchymal transition and cellular senescence.
Yongqing Liu, Shahenda El-Naggar, Douglas S Darling, Yujiro Higashi, Douglas C Dean. Development 2008
218
10

Stimulation of Wnt/β-Catenin Signaling to Improve Bone Development by Naringin via Interacting with AMPK and Akt.
Dawei Wang, Wenpu Ma, Fu Wang, Jinlei Dong, Dan Wang, Bo Sun, Bomin Wang. Cell Physiol Biochem 2015
43
10


Effect of naringin on bone cells.
R W K Wong, A B M Rabie. J Orthop Res 2006
35
10



Naringin inhibits ovarian tumor growth by promoting apoptosis: An in vivo study.
Liping Cai, Heli Wu, Chunhua Tu, Xiaochun Wen, Bei Zhou. Oncol Lett 2018
8
12

Epithelial-mesenchymal transition, a novel target of sulforaphane via COX-2/MMP2, 9/Snail, ZEB1 and miR-200c/ZEB1 pathways in human bladder cancer cells.
Yujuan Shan, Lanwei Zhang, Yongping Bao, Baolong Li, Canxia He, Mingming Gao, Xue Feng, Weili Xu, Xiaohong Zhang, Shuran Wang. J Nutr Biochem 2013
91
10

ZEB proteins link cell motility with cell cycle control and cell survival in cancer.
Gareth Browne, A Emre Sayan, Eugene Tulchinsky. Cell Cycle 2010
82
10

Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting β-catenin signaling pathway.
Hongzhong Li, Bing Yang, Jing Huang, Tingxiu Xiang, Xuedong Yin, Jingyuan Wan, Fuling Luo, Li Zhang, Hongyuan Li, Guosheng Ren. Toxicol Lett 2013
60
10

ZEB1-repressed microRNAs inhibit autocrine signaling that promotes vascular mimicry of breast cancer cells.
E M Langer, N D Kendsersky, C J Daniel, G M Kuziel, C Pelz, K M Murphy, M R Capecchi, R C Sears. Oncogene 2018
33
10

Suppression of lipopolysaccharide-induced tumor necrosis factor-release and liver injury in mice by naringin.
K Kawaguchi, S Kikuchi, H Hasegawa, H Maruyama, H Morita, Y Kumazawa. Eur J Pharmacol 1999
60
10

The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity.
K Aigner, B Dampier, L Descovich, M Mikula, A Sultan, M Schreiber, W Mikulits, T Brabletz, D Strand, P Obrist,[...]. Oncogene 2007
451
10

Naringin suppresses the metabolism of A375 cells by inhibiting the phosphorylation of c-Src.
Bingyu Guo, Yu Zhang, Qiang Hui, Hongyi Wang, Kai Tao. Tumour Biol 2016
14
10

Naringin enhances osteogenic differentiation through the activation of ERK signaling in human bone marrow mesenchymal stem cells.
Huichao Wang, Chunbo Li, Jianming Li, Yingjie Zhu, Yudong Jia, Ying Zhang, Xiaodong Zhang, Wenlong Li, Lei Cui, Wuyin Li,[...]. Iran J Basic Med Sci 2017
24
10

Naringin inhibits growth and induces apoptosis by a mechanism dependent on reduced activation of NF‑κB/COX‑2‑caspase-1 pathway in HeLa cervical cancer cells.
Lan Zeng, Yulan Zhen, Yiming Chen, Lin Zou, Ying Zhang, Fen Hu, Jianqiang Feng, Jianhua Shen, Bing Wei. Int J Oncol 2014
52
10

ZEB1 stimulates breast cancer growth by up-regulating hTERT expression.
Pan Yu, Xi Shen, Wen Yang, Yunke Zhang, Chunping Liu, Tao Huang. Biochem Biophys Res Commun 2018
18
10

Loss of E-cadherin activates EGFR-MEK/ERK signaling, which promotes invasion via the ZEB1/MMP2 axis in non-small cell lung cancer.
Gab-Yong Bae, So-Jung Choi, Ji-Seon Lee, Jisuk Jo, Jinseon Lee, Jhingook Kim, Hyuk-Jin Cha. Oncotarget 2013
114
10

The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer.
Karen Hanrahan, Amanda O'Neill, Maria Prencipe, Jane Bugler, Lisa Murphy, Aurelie Fabre, Martin Puhr, Zoran Culig, Keefe Murphy, R William Watson. Mol Oncol 2017
80
10

18F-FDG Uptake During Early Adjuvant Chemotherapy Predicts Histologic Response in Pediatric and Young Adult Patients with Osteosarcoma.
James C Davis, Najat C Daw, Fariba Navid, Catherine A Billups, Jianrong Wu, Armita Bahrami, Jesse J Jenkins, Scott E Snyder, Wilburn E Reddick, Victor M Santana,[...]. J Nucl Med 2018
25
10

Naringin abrogates osteoclastogenesis and bone resorption via the inhibition of RANKL-induced NF-κB and ERK activation.
Estabelle S M Ang, Xiaohong Yang, Honghui Chen, Qian Liu, Ming H Zheng, Jiake Xu. FEBS Lett 2011
76
10

Therapeutic potential of naringin: an overview.
Rui Chen, Qiao-Ling Qi, Meng-Ting Wang, Qi-Yan Li. Pharm Biol 2016
114
10

Naringin induces autophagy-mediated growth inhibition by downregulating the PI3K/Akt/mTOR cascade via activation of MAPK pathways in AGS cancer cells.
Suchismita Raha, Silvia Yumnam, Gyeong Eun Hong, Ho Jeong Lee, Venu Venkatarame Gowda Saralamma, Hyeon-Soo Park, Jeong Doo Heo, Sang Joon Lee, Eun Hee Kim, Jin-A Kim,[...]. Int J Oncol 2015
71
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.